Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis
暂无分享,去创建一个
V. Meininger | F. Salachas | N. le Forestier | L. Lacomblez | P. Pradat | G. Bruneteau | T. Lenglet | E. Munerati
[1] N. Quinn,et al. Primary lateral sclerosis mimicking atypical parkinsonism , 2007, Movement disorders : official journal of the Movement Disorder Society.
[2] S. Tsuji,et al. A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis. , 2006, Archives of neurology.
[3] W. Rymer,et al. The role of shortening reaction in mediating rigidity in Parkinson’s disease , 2004, Experimental Brain Research.
[4] P N Leigh,et al. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. , 2000, Brain : a journal of neurology.
[5] W. Oyen,et al. Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration , 2000, Journal of the Neurological Sciences.
[6] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[7] M. Swash,et al. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion , 1999, Journal of neurology, neurosurgery, and psychiatry.
[8] M. Horstink,et al. Decreased striatal dopamine-receptor binding in sporadic ALS: Glutamate hyperactivity? , 1999, Neurology.
[9] G. Borasio,et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography , 1998, Journal of neurology, neurosurgery, and psychiatry.
[10] L S Illis,et al. Neurotrauma , 1998, Spinal Cord.
[11] J. Lowe,et al. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.
[12] S. Tsuji,et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration , 1997, Journal of the Neurological Sciences.
[13] V. Dhawan,et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations , 1996, Neurology.
[14] R. Ruff,et al. Principles of Neurology, 5th Ed. , 1995, Neurology.
[15] S. Wood-Dauphinée,et al. The Balance Scale: reliability assessment with elderly residents and patients with an acute stroke. , 1995, Scandinavian journal of rehabilitation medicine.
[16] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[17] B. Snow,et al. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning , 1993, The Lancet.
[18] M. Oda,et al. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis , 1993, Neuropathology and applied neurobiology.
[19] P. Blumbergs,et al. Substantia nigra degeneration in motor neurone disease: a quantitative study. , 1992, Australian and New Zealand journal of medicine.
[20] E. Borrelli,et al. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. , 1992, Brain research. Molecular brain research.
[21] Richard W. Bohannon,et al. Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.
[22] R. Angel. Shortening reaction in normal and parkinsonian subjects , 1982, Neurology.
[23] W. Grove. Statistical Methods for Rates and Proportions, 2nd ed , 1981 .
[24] F. Norris,et al. Trial of baclofen in amyotrophic lateral sclerosis. , 1979, Archives of neurology.
[25] R. Angel,et al. Unloading and shortening reactions in Parkinson's disease. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[26] P. Rondot,et al. Muscle reaction to passive shortening in normal man. , 1978, Electroencephalography and clinical neurophysiology.
[27] A. Faurbye,et al. DEPOSITS IN THE LENS AND CORNEA OF THE EYE DURING LONG‐TERM CHLORPROMAZINE MEDICATION , 1976, Acta psychiatrica Scandinavica.
[28] W. Conover. Statistical Methods for Rates and Proportions , 1974 .
[29] P. Castaigne,et al. [Neuropathological study of 61 cases of amyotrophic lateral sclerosis. Nosological discussion]. , 1972, Revue neurologique.
[30] J. Scherrer,et al. [Reflex contraction induced by passive shortening of the muscle in athetosis and position dystonias]. , 1966, Revue neurologique.
[31] C. Westphal. Unterschenkelphänomen und Nervendehnung , 1877, Archiv für Psychiatrie und Nervenkrankheiten.
[32] Y. Tsutsumi,et al. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement , 2004, Acta Neuropathologica.
[33] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[34] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[35] C. Broberg,et al. Measurement of torque during passive and active ankle movements in patients with muscle hypertonia. A methodological study. , 1983, Scandinavian journal of rehabilitation medicine. Supplement.
[36] D. Burke,et al. The response to muscle stretch and shortening in Parkinsonian rigidity. , 1972, Brain : a journal of neurology.